| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 04/14/2009 | US7517904 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 04/14/2009 | US7517891 7-[4'S,5'R-4',6'-di-O-acetyl-2',3'-dideoxy-D-erythro-hex-2'-enopyranosyl]-oxymethyl camptothecin 20-(4-bromo)-n-butyrate; breast cancers, ovarian cancer, colon cancer, malignant melanoma, small cell lung cancer, thyroid cancers, lymphomas, leukemias, AIDS |
| 04/14/2009 | US7517883 Solubilized topoisomerase poisons |
| 04/14/2009 | US7517867 Topoisomerase inhibitors; useful as antibacterial, antifungal agents; cancer; structure is based on substituted benzo(i)phenanthridine ring where the ring carbon atoms at position 5 and 11 are optionally replaced by nitrogen |
| 04/14/2009 | US7517532 Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
| 04/14/2009 | US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 04/09/2009 | WO2009043883A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
| 04/09/2009 | WO2008151927A3 6-n-substituted benz imidazole derivatives as acid pump antagonists |
| 04/09/2009 | WO2007123732A3 Antifungal and antiparasitic indoloquinoline derivatives |
| 04/09/2009 | US20090093623 4,7-dichlororhodamine dyes |
| 04/08/2009 | EP2045252A2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 04/08/2009 | EP2045242A1 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/08/2009 | EP2044080A1 Camptothecin derivatives with antitumor activity |
| 04/08/2009 | EP2044079A1 Camptothecin derivatives with antitumor activity |
| 04/08/2009 | EP2044078A1 Camptothecin derivatives with antitumor activity |
| 04/08/2009 | EP2044077A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 04/08/2009 | EP2044076A1 Process for the preparation of asenapine and intermediate products used in said process. |
| 04/08/2009 | EP2044075A1 Furo [3, 2-b] pyrrol derivatives |
| 04/08/2009 | EP2044073A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 04/08/2009 | EP2044035A1 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement |
| 04/08/2009 | EP2043646A2 Glucocorticoid receptor modulator and methods of use |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | CN101405284A Pyrimidine, quinazoline, pteridine and derivatives |
| 04/08/2009 | CN101405278A Novel heterocyclic NF-kB inhibitors |
| 04/08/2009 | CN101405265A Amido compounds and their use as pharmaceuticals |
| 04/08/2009 | CN101402640A Diester camptothecin derivative, preparation method and uses thereof |
| 04/08/2009 | CN101402639A 20(S)-7-(2-furoyl) camptothecinum and synthesis thereof |
| 04/08/2009 | CN101402638A 20(S)-7-pentanoyl camptothecinum and synthesis thereof |
| 04/08/2009 | CN101402637A Process for producing protopine total alkaloids extract |
| 04/08/2009 | CN101402623A 3-substituted benzene phthalein compounds with biological activity |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN100475822C Synthesis method for producing ecteinascidin compound |
| 04/08/2009 | CN100475818C Indolinospiropyran compounds and methods for manufacture |
| 04/07/2009 | US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/07/2009 | US7514449 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 04/07/2009 | US7514448 Azaindoles useful as inhibitors of rock and other protein kinases |
| 04/07/2009 | US7514437 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 04/07/2009 | US7514431 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 04/07/2009 | US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists |
| 04/07/2009 | US7514418 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 04/07/2009 | CA2352505C Epothilone derivatives and their use as antitumor agents |
| 04/07/2009 | CA2341991C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 04/02/2009 | WO2009041521A1 Quinolone derivative |
| 04/02/2009 | US20090088568 Vinorelbine derivatives |
| 04/02/2009 | US20090088420 Compounds with hiv-1 integrase inhibitory activity and use thereof as anti-hiv/aids therapeutics |
| 04/02/2009 | US20090088407 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | DE102007057869B3 Quarzglas-Mikrophotoreaktor und Synthese von 10-Hydroxycamptothecin und 7-Alkyl-10-hydroxycamptothecin Quartz glass micro-photoreactor and synthesis of 10-hydroxycamptothecin and 7-alkyl-10-hydroxycamptothecin |
| 04/02/2009 | CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | CA2700088A1 Quinolone derivative |
| 04/01/2009 | EP2041142A1 Spirocyclic azaindole derivatives |
| 04/01/2009 | EP2041141A2 Benzopyranopyrazoles |
| 04/01/2009 | EP2041140A2 Aziridinyl-epothilone compounds |
| 04/01/2009 | EP2041139A2 Pharmaceutical compounds |
| 04/01/2009 | EP1646661B1 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
| 04/01/2009 | EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 04/01/2009 | CN101400682A Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia |
| 04/01/2009 | CN101397302A 9-substituted homocamptothecins compounds and its use as medicaments |
| 04/01/2009 | CN101397301A Water-soluble derivates containing 10-hydroxycamptothecin and preparation method |
| 04/01/2009 | CN100473654C S type 4-substituted hydroxypyranoindolidine compound and derivatives and preparation thereof |
| 04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |
| 04/01/2009 | CN100473647C Pyridazinones and triazinones and medicinal use thereof |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511156 Analogs of Salinosporamide A |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511071 Thioamide derivatives as progesterone receptor modulators |
| 03/31/2009 | US7511057 Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors |
| 03/31/2009 | US7511056 TGF-β inhibitors |
| 03/31/2009 | US7511054 Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs |
| 03/31/2009 | US7511050 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders |
| 03/31/2009 | US7511048 Hyperproliferative disorders; packages |
| 03/31/2009 | US7511041 Fused azole-pyrimidine derivatives |
| 03/31/2009 | US7511037 N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor |
| 03/26/2009 | WO2009038974A1 Compounds and compositions as modulators of gpr119 activity |
| 03/26/2009 | WO2009037220A1 Tricyclic heterocyclic derivatives |
| 03/26/2009 | WO2009037111A2 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions |
| 03/26/2009 | WO2009037001A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 03/26/2009 | WO2008142542A3 Processes for preparing benzofuro [3, 2-c] pyridine- 9-carbaldehyde derivatives as novel intermediates for the synthesis of pde iv inhibitors |
| 03/26/2009 | WO2008141731A3 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 03/26/2009 | US20090082417 Deuterium-enriched sdx-101 |
| 03/26/2009 | US20090082348 Indazole derivatives |
| 03/26/2009 | CA2705719A1 Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| 03/26/2009 | CA2699909A1 Process for preparing 1,3-dioxolan-2-ones as well as carboxylic acid esters by transacylation under basic reaction conditions |
| 03/26/2009 | CA2698436A1 Tricyclic heterocyclic derivatives |
| 03/26/2009 | CA2697551A1 Piperidine derivatives as modulators of gpr119 activity |
| 03/26/2009 | CA2696725A1 Pyridine derivatives and methods of use thereof |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP2038287A1 Spiro[benzopyran]or spiro[benzofuran]derivatives which inhibit the sigma receptor |
| 03/25/2009 | EP2038264A1 Tetrazole-substituted arylamides |
| 03/25/2009 | EP2037916A2 Pure isomers of tritoqualine |
| 03/25/2009 | EP2000540A9 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1697379B1 Spirocyclic cyclohexane derivatives |
| 03/25/2009 | EP1636218B1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 03/25/2009 | CN101391999A Method for preparing dehydration tetrodotoxin high purity monomer |
| 03/25/2009 | CN101391998A High efficiency separation and purification method of camptothecine |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/24/2009 | US7507825 Condensation of 7-ethyl-10-hydroxycamptothecin with 1-chlorocarbonyl-4-piperidinopiperidine hydrochloride in a polar aprotic solvent in the presence of 4-dimethylaminopyridine; topoisomerase inhibitor which is used in treatment of lung and rectum cancer |